Episodes

Lewis Silverman, MD, Boston Children’s Hospital, Boston, MA Recorded on February 7, 2019 Learn more as Dr. Lewis Silverman, a pediatric hematologist-oncologist at Boston Children’s Hospital in Boston, MA, discusses medical advances in pediatric hematologic malignancies, the role of immunotherapy, late relapse, the role of checkpoint inhibitors, and improving the quality of cure with a focus on acute lymphoblastic leukemia. Lewis Silverman, MD Pediatric Hematologist-Oncologist Boston Childre...

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on December 28, 2018 The conversation continues with Dr. Richardson in Part II of a two part episode on myeloma by describing the phases of treatment: induction remission therapy, consolidation and maintenance. Dr. Richardson provides an in-depth view of real-world issues patients experience, describes combination drug therapies and new treatments, addresses the clinical benefit of transplant for individual patients and the...

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on December 28, 2018 On Part I of a two part episode, Dr. Ken Miller talks with Dr. Paul Richardson, a hematologist/oncologist at Dana-Farber Cancer Center in Boston, MA, as he describes his journey as a clinical investigator and how that journey shaped his perspective when treating patients. Dr. Richardson discusses the biology of the disease, state-of-the-art care, how smoldering myeloma differs from the disease of myelom...

Alice Mims, MD, MSCR, The James, The Ohio State University Comprehensive Cancer Center, Columbus, OH Recorded on January 10, 2019 For many decades, treatment for AML remained stagnant. In recent years, new options have emerged. Join Dr. Ken Miller as he questions Dr. Alice Mims of The Ohio State University Comprehensive Cancer Center in Columbus, Ohio about these treatment updates. Dr. Mims also discusses how to tailor treatment to the patient’s goals of care, common mutations found in AML, an...

Naveen Pemmaraju, MD, MD Anderson Cancer Center, Houston, TX Recorded on December 11, 2018 Join Drs. Naveen Pemmaraju and Ken Miller as they discuss the diagnosis, treatment, and management of blastic plasmacytoid dendritic cell neoplasm (BPDCN), an often misdiagnosed and highly aggressive hematologic malignancy. Dr. Pemmaraju is a hematologist/oncologist at MD Anderson Cancer Center in Houston, TX. On this episode, Dr. Pemmaraju discusses the origin of BPDCN, methods of diagnosing and treatin...